Nouscom will present at Biocapital Europe By fabiocrognale Posted 02/06/2018 In External Presentations Nouscom will present at Biocapital Europe2018-02-062018-05-14http://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.pngNouscomhttp://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.png200px200px Find out the full program here: http://www.biocapitaleurope.com Recent PostsNouscom announces appointment of Yen Ching as Vice President of Clinical OperationsNouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal CancerDr. Marina Udier comments the Neoantigen vaccine report card issued by BioCenturyNouscom Announces First Patient Dosed in Phase 2 Randomized Trial with NOUS-209, an ‘off-the shelf’ Neoantigen Cancer Immunotherapy in dMMR/MSI-High Metastatic Colorectal Cancer